Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 14, 2017; 23(46): 8140-8151
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8140
Published online Dec 14, 2017. doi: 10.3748/wjg.v23.i46.8140
Group | |||
Parameter | Control(n = 10) | HFD(n = 10) | Liraglutide(n = 10) |
ALT, in U/L | 37.4 ± 1.9 | 114.3 ± 26.7a | 34.3 ± 3.1c |
AST, in U/L | 92.1 ± 5.6 | 160.1 ± 16.8a | 90.2 ± 5.5c |
HDL, in mmol/L | 0.33 ± 0.01 | 0.25 ± 0.01a | 0.24 ± 0.01a |
LDL, in mmol/L | 0.14 ± 0.01 | 0.42 ± 0.04a | 0.53 ± 0.07a |
- Citation: Liu XL, Cao HX, Wang BC, Xin FZ, Zhang RN, Zhou D, Yang RX, Zhao ZH, Pan Q, Fan JG. miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1. World J Gastroenterol 2017; 23(46): 8140-8151
- URL: https://www.wjgnet.com/1007-9327/full/v23/i46/8140.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i46.8140